INTRODUCTION
Since the report by Gluck et al. 1 about the use of the lecithin/ sphingomyelin (L/S) ratio in amniotic fluid (AF) samples to predict the likelihood of respiratory distress syndrome (RDS), determinations of many other potential markers of fetal lung maturation have been described. 1 -8 These include measurements of the concentration of saturated phosphatidylcholine (Sat PC) and surfactant proteins, among others. 2, 4, 7, 8 All of them increase with advancing gestational age and reflect directly or indirectly the amount of surfactant secreted by type II pneumocytes from the developing fetal lung.
Clara cell protein (CCP) is a 16-kDa protein secreted by nonciliated cells of the bronchial and bronchiolar epithelium including Clara cells. 9, 10 This protein is synthesized in the developing fetal airways and can be quantified in AF as early as 15 to 16 weeks of gestation. 11 The concentration of CCP in AF increases progressively with advancing gestation. 5 Although it is also secreted by the male urogenital tract from puberty onwards, this source is not very active during the fetal period and therefore may not influence AF levels of this protein. 5 Even though no specific function in the respiratory tract has been attributed to CCP, it is significantly reduced in AF of fetuses with congenital diaphragmatic hernia. 11, 12 This observation and the fact that there seems to be some correlation with the presence of lung hypoplasia have suggested that the concentration of CCP in AF could be a marker of fetal airway growth. Whether the changes in CCP measured in AF are also related to the process of fetal lung maturation still remains unclear. The purpose of our study was to evaluate the correlation of CCP with well-known AF markers of fetal lung maturation. Our hypothesis was that the concentration of CCP in AF would not exhibit a direct correlation with the L/S ratio, or the concentrations of Sat PC and surfactant protein A (SP-A).
OBJECTIVE:
To evaluate the relationship of Clara cell protein ( CCP ) in amniotic fluid ( AF ) with the lecithin / sphingomyelin ( L / S ) ratio, and the concentrations of saturated phosphatidylcholine ( Sat PC ) and surfactant protein A ( SP -A ).
STUDY DESIGN:
AF samples were obtained by amniocentesis from 98 pregnancies without conditions known to influence fetal lung maturation between 25 and 41 weeks of gestation. These samples were used for determinations of CCP, L / S ratio, Sat PC, and SP -A. Simple and multiple linear regressions were used to analyze the data. Original Article
MATERIALS AND METHODS
We used 98 AF samples obtained by amniocentesis between 25 and 41 weeks of gestation, from pregnant women at risk for preterm delivery or infection (Hospital Clínico, Universidad Católica, Santiago, Chile), between 1992 and 1995. The decision to perform the amniocentesis was made by the attending physician and not for the purpose of this investigation. The patients were not eligible if there was any evidence of fetal malformations, abnormal fetal growth, chorioamnionitis, or if they had received antenatal corticosteroids. Diabetic women were also excluded. After a brief centrifugation, the AF samples were stored at À208C until analyzed for CCP, L/S ratio, Sat PC, SP-A, and total protein. When the quantity of AF was not sufficient for all determinations, the following priority order was used: CCP, total protein, SP-A, Sat PC, and L/S ratio. An additional group of 18 AF samples obtained for genetic purposes from pregnancies between 14 and 24 weeks of gestation was used to establish the changes of CCP across gestation, but these results were not included in the comparisons between CCP and other AF markers because neither SP-A nor Sat PC is detectable at this point of pregnancy.
Determinations in AF
All determinations were done blindly.
Clara cell protein.
The concentration of CCP in AF was determined as described by Bernard et al. 11 in their laboratory. In brief, this immunoassay uses the anti-protein 1 antibody (Dakopatts, Glostrup, Denmark) and as a standard, purified CCP. This is expressed in nanograms per milliliter and the limit of detection of the assay is 15 ng/ml. The interassay and intra-assay variabilities for these determinations were 5% and 10%, respectively.
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Total protein. Aliquots of AF were used for total protein determinations by the method of Lowry et al. 13 using bovine serum albumin as a standard. Total protein is expressed in milligrams per milliliter.
Surfactant protein A. The quantity of SP-A in AF was determined by ELISA using a rabbit anti-human SP-A polyclonal antibody as previously described. 7, 14 Briefly, duplicates of three serial dilutions of each sample were used to calculate the final SP-A concentration. Samples were loaded into the 96-microwell plates varying the amount of protein, if necessary, to obtain an SP-A reading in the linear part of the curve. Preadsorption with type O Rh+ human serum was done to remove antibodies against other serum proteins (albumin) and then the rabbit polyclonal antibody was incubated with the samples overnight at 48C. After 24 hours, the free antibody was transferred into a similar 96-microwell plate previously coated with purified SP-A. Antibody binding was allowed for 30 minutes. A series of washes was done with phosphate-buffered saline (PBS) and Tween 20 buffer to remove unbound antibody. Peroxidaseconjugated goat anti-rabbit IgG antibody was added and allowed to bind for 2 hours at room temperature. The reaction was stopped with 5% sodium dodecyl sulfate and the plate was read at 450 nm using an ELISA reader. SP-A is expressed in micrograms per milliliter.
Sat PC and L/S ratio. Lipid extractions were performed in samples of AF using the method of Bligh and Dyer. 15 Sat PC was then separated by thin layer chromatography in silica gel plates after treating with osmium tetroxide as described by Mason et al. 16 The Sat PC spot was visualized with UV light using 6-p-toluidine-2-naphthalene-sulfonic acid, and phospholipid phosphorus was quantified by the method of Rouser et al. 17 Sat PC is expressed in nanomoles per milliliter. The L/S ratio was determined as previously described by Touchstone et al. 18 
Statistical Analysis
The relationships between the AF markers were analyzed using simple and multiple linear regressions. 19 The best curve fit and the 95% confidence intervals for the population were calculated using Sigma Stat and Sigma Plot v4.00 software (SPSS Corp.). Only independent variables significantly associated (p<0.05) with the outcome variables were included in multiple linear regression equations.
RESULTS
Given the variable rate of rise of the different components of AF analyzed, the best curve fit for all of them was achieved by a secondorder polynomial regression. Low quantities of CCP were detectable between 14 and 18 weeks of gestation. There was a logarithmic increase in AF concentrations of CCP with advancing gestation (n=116, R 2 =0.51, p=0.006, Figure 1 ), although its rate of rise was slower after 30 to 32 weeks of pregnancy. The L/S ratio values were <1.5 until about 32 to 34 weeks of gestation when they increased progressively (n=70, R 2 =0.41, p=0.001, Figure 2A ). Sat PC values were barely detectable until approximately 30 to 32 weeks of gestation and exhibited a steady increase thereafter (n=96, R 2 =0.26, p=0.001, Figure 2B ). SP-A concentrations in AF showed a similar developmental increase (n=98, R 2 =0.54, p=0.001, Figure  2C ). The concentration of total protein in AF decreased progressively throughout the second half of pregnancy (n=98, R 2 =0.27, p=0.0001, data not shown).
The relationship of CCP with the other markers was assessed using only the 98 AF samples obtained between 25 and 41 weeks of gestation. Before this point of pregnancy, Sat PC and SP-A are rarely detectable. There was a very weak but significant correlation between the AF concentration of CCP with the L/S ratio (R 2 =0.22, p=0.009) and Sat PC (R 2 =0.12, p=0.004), although no significant correlation was found between CCP and SP-A (R 2 =0.07, p=0.108). There was a stronger correlation between L/S ratio with Sat PC (R 2 =0.32, p<0.00001) and SP-A (R 2 =0.29, p<0.00001). Also, SP-A was correlated with Sat PC (R 2 =0.28, p<0.00001). Using multiple linear regression, the only independent variable that predicted the values of CCP in AF was gestational age (F=10.9, R 2 =0.13, p=0.001), whereas most of the increases of the L/S ratio and SP-A were predicted by gestational age, Sat PC, and SP-A (F=34.7, R 2 =0.61, p<0.00001), or by gestational age and the L/S ratio (F=17.0, R 2 =0.33, p<0.00001), respectively. A very small number of neonates were delivered within 2 to 3 days from amniocentesis and only four of them developed RDS, making predictions of the likelihood of this disease using the various AF markers difficult to establish. We found no differences between the concentrations of CCP in tracheal fluid samples obtained within 12 days after birth from eight preterm neonates with and without RDS (1319±1054 vs. 1147±380 ng/mg of total protein, mean±SD, respectively).
DISCUSSION
Our data confirm that CCP can be detected in AF early in pregnancy and increases rapidly throughout gestation. 11 A similar protein can also be secreted by the urogenital tract from puberty onwards, but this source is not very active during the fetal period and does not influence the AF levels of this protein. 20 Detection of CCP in AF coincides with the appearance of Clara cells in human fetal lung, although other bronchial nonciliated epithelial cells are also capable of secreting this protein. 9, 10, 21 We observed a marked rise of CCP in AF before 30 to 32 weeks of gestation, which probably is a reflection of the growth of the fetal airways, of an increase in the number of cells capable of secreting CCP, and developmental changes of the expression of CCP in those cells. 9, 10, 22 Singh et al. 23 reported similar observations in the developing rat. In fetal rabbits, the numerical density of nonciliated bronchiolar cells decreases toward term. 24 This finding may contribute to explain why CCP concentrations in AF increase at a much slower rate during late gestation.
The changes of the L/S ratio, Sat PC, SP-A, and total protein that we observed are all in keeping with previous studies by us and other investigators. 1 -4,7,8,25 Moreover, the correlation of the L/S ratio with Sat PC and SP-A values is similar to that reported by other investigators. 4, 7, 8 Determinations of the L/S ratio and Sat PC in AF measure phospholipids from several sources including the fetal lung, whereas all the SP-A found in AF derives exclusively from this developing organ. 7, 8, 25 These facts, as well as differences in the onset of the synthesis of these surfactant components by the developing lung, probably contribute to explain the variation in their correlations. 26 -28 Further variability may derive from the finding that SP-A can be secreted by type II pneumocytes independently of the phospholipid-rich lamellar bodies. 29, 30 The concentration of CCP in AF has been suggested as a marker of fetal lung growth, based on its time course during normal pregnancy and the finding of reduced levels of this protein with fetal lung hypoplasia. 11, 12 We have reported that the concentrations of Sat PC and SP-A in AF are also decreased in human fetuses with diaphragmatic hernia, many of which had lung hypoplasia. 25 However, it is unclear if these findings represent delays in fetal lung maturation or merely reflect the hypoplasia of the fetal lungs associated with that anomaly. 28 In the present study of pregnancies with normal fetuses, we have shown that the AF concentration of CCP has essentially no relationship with markers of fetal lung maturation related to surfactant synthesis and secretion. Furthermore, we found no correlation between CCP and SP-A, which derive only from the fetal lung, even though both proteins can be synthesized by Clara cells. 10 Moreover, the only predictor of increasing CCP concentrations in AF was gestational age. Our observations suggest that the concentration of CCP in AF is a reflection of growth and development of the fetal airways and is not markedly influenced by the onset of surfactant synthesis. Further support for this hypothesis is rendered by the lack of differences in CCP observed in tracheal fluid samples obtained from preterm infants with or without RDS.
CONCLUSION
We conclude that AF concentrations of CCP reflect primarily growth and development of the fetal airways. Furthermore, we speculate that determinations of CCP and other AF markers of fetal lung development may be helpful to distinguish between the degree of hypoplasia of the airways and delays in lung maturation in fetuses with abnormal lung growth.
